What is LOPJLB’s current signal on INDP?

LOPJLB’s latest quantitative signal on Indaptus Therapeutics, Inc. (INDP) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is INDP in?

Indaptus Therapeutics, Inc. (INDP) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Indaptus Therapeutics, Inc. (INDP) do?

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeuti…

Where is Indaptus Therapeutics, Inc. based / listed?

Indaptus Therapeutics, Inc. is based in US, listed on NASDAQ.

Indaptus Therapeutics, Inc. (INDP)

Healthcare · Biotechnology · NASDAQ · US

$1.16-10.08%Close

SELLCRISIS · day 21

[SCORES & PROFILE]

FUND: 13
VALUE: 5
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-181.7%

REV YoY-

ROE-302.8%

EPS YoY-

ROA-128.7%

GROSS

NET

[VALUATION]

P/E TTM-0.21

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B11.85

P/FCF-

EV/EBITDA-8.01

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO19.48

ND/EBITDA-

BETA1.18

Indaptus Therapeutics, Inc. (INDP)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news